Sales/Maturities of Investments

$1.19B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$1.19Bperiod endingJun 30, 2026

NVS Sales/Maturities of Investments ($0.00 → $1.19B)

Annual Sales/Maturities of Investments

High-resolution chart · PNG

NVS sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Sales/Maturities of Investments — Annual fiscal periods (USD)
Period ending	Sales/Maturities of Investments (USD)
Dec 31, 2025	2,188,148,000
Dec 31, 2024	3,701,000,000
Dec 31, 2023	11,596,000,000
Dec 31, 2022	39,490,000,000
Dec 31, 2021	2,738,000,000
Dec 31, 2020	1,215,000,000
Dec 31, 2019	3,713,000,000
Dec 31, 2018	639,000,000
Dec 31, 2017	879,000,000
Dec 31, 2016	869,000,000
Dec 31, 2015	428,000,000
Dec 31, 2014	2,517,000,000
Dec 31, 2013	564,000,000
Dec 31, 2012	737,000,000
Dec 31, 2011	3,409,000,000
Dec 31, 2010	53,269,000,000
Dec 31, 2009	3,762,000,000
Dec 31, 2008	7,404,000,000
Dec 31, 2007	4,253,000,000
Dec 31, 2006	5,631,000,000
Dec 31, 2005	7,432,000,000
Dec 31, 2004	7,011,000,000
Dec 31, 2003	10,511,000,000
Dec 31, 2002	7,860,000,000
Dec 31, 2001	1,553,000,000
Dec 31, 2000	2,951,000,000
Dec 31, 1999	180,000,000
Dec 31, 1998	0